With the precision of monoclonal antibodies and the potency of small-molecular payloads, antibody-drug conjugates (ADC) are promising cancer therapeutics. As of this year, there are 19 ADC drugs ...
The tradeoff between integrated and standalone ADCs regarding performance, specification, complexity, robustness, and cost. How to evaluate which analog technology to use to meet your application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results